Ginkgo Bioworks Holdings Inc
NYSE:DNA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ginkgo Bioworks Holdings Inc
NYSE:DNA
|
US |
|
M
|
Myriad Genetics Inc
F:MYD
|
US |
|
I
|
Inchcape PLC
XBER:IJCA
|
UK |
|
Levi Strauss & Co
NYSE:LEVI
|
US |
|
Kura Sushi USA Inc
NASDAQ:KRUS
|
US |
|
Merck & Co Inc
NYSE:MRK
|
US |
|
N
|
NRJ Group SA
XBER:NR8
|
FR |
|
S
|
SPS Finquest Ltd
BSE:538402
|
IN |
|
C
|
Constellation Brands Inc
F:CB1A
|
US |
|
Bilfinger SE
XETRA:GBF
|
DE |
|
T
|
Terreno Realty Corp
F:T37
|
US |
|
Lovesac Co
NASDAQ:LOVE
|
US |
Wall St Price Targets
DNA Price Targets Summary
Ginkgo Bioworks Holdings Inc
According to Wall Street analysts, the average 1-year price target for DNA is 10.2 USD with a low forecast of 9.09 USD and a high forecast of 12.6 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DNA's stock price target?
Price Target
10.2
USD
According to Wall Street analysts, the average 1-year price target for DNA is 10.2 USD with a low forecast of 9.09 USD and a high forecast of 12.6 USD.
What is the Revenue forecast for Ginkgo Bioworks Holdings Inc?
Projected CAGR
21%
Over the last 5 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 21%.
What is the Gross Profit forecast for Ginkgo Bioworks Holdings Inc?
Projected CAGR
24%
Over the last 5 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 3 years is 24%.
